Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PRTC.L Stock Summary
Top 10 Correlated ETFs
PRTC.L
In the News
PRTC.L Financial details
Company Rating
Neutral
Market Cap
583.65M
Income
-47.01M
Revenue
11.74M
Book val./share
1.85
Cash/share
1.27
Dividend
-
Dividend %
-
Employees
111
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
-19.65
Forward P/E
-346.15
PEG
8.61
P/S
332.47
P/B
1.34
P/C
177.17
P/FCF
-3.84
Quick Ratio
3.61
Current Ratio
3.99
Debt / Equity
0.05
LT Debt / Equity
0.04
-
-
EPS (TTM)
-0.17
EPS next Y
-0.65
EPS next Q
-
EPS this Y
-40.91%
EPS next Y
283.33%
EPS next 5Y
186.72%
EPS last 5Y
-12.94%
Revenue last 5Y
-33.75%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
9.2%
SMA50
12.59%
SMA100
38.34%
Inst Own
0.09%
Inst Trans
1%
ROA
-5%
ROE
-7%
ROC
-0.33%
Gross Margin
100%
Oper. Margin
-9464%
Profit Margin
-1773%
Payout
-
Shs Outstand
270.21M
Shs Float
242.77M
-
-
-
-
Target Price
-
52W Range
139.0-242.925
52W High
-7.02%
52W Low
+61.87%
RSI
63.1
Rel Volume
0.13
Avg Volume
572.49K
Volume
73.84K
Perf Week
10.29%
Perf Month
24.31%
Perf Quarter
22.42%
Perf Half Y
11.11%
-
-
-
-
Beta
0.942
-
-
Volatility
4.16%, 12.59%
Prev Close
0.9%
Price
225
Change
-0.88%
PRTC.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.06 | 0.03 | 0.03 | 0.03 | 0.01 | |
Net income per share | -0.26 | 1.49 | 0.02 | -0.22 | -0.13 | |
Operating cash flow per share | -0.27 | -0.35 | -0.46 | -0.55 | -0.64 | |
Free cash flow per share | -0.28 | -0.39 | -0.48 | -0.57 | -0.65 | |
Cash per share | 0.92 | 0.57 | 1.41 | 1.62 | 1.25 | |
Book value per share | 1.01 | 2.36 | 2.35 | 2.07 | 1.94 | |
Tangible book value per share | 0.6 | 2.29 | 2.29 | 2.03 | 1.95 | |
Share holders equity per share | 1.01 | 2.36 | 2.35 | 2.07 | 1.94 | |
Interest debt per share | 0.05 | 0.15 | 0.28 | 0.2 | 0.18 | |
Market cap | 595.68M | 1.19B | 1.56B | 1.13B | 902.08M | |
Enterprise value | 491M | 1.1B | 1.23B | 715.92M | 799.09M | |
P/E ratio | -8.43 | 2.82 | 340.89 | -18.01 | -24.34 | |
Price to sales ratio | 36.39 | 136.89 | 186.69 | 113.2 | 431.62 | |
POCF ratio | -8.18 | -12.12 | -11.81 | -7.14 | -5.05 | |
PFCF ratio | -7.71 | -10.74 | -11.35 | -6.89 | -4.98 | |
P/B Ratio | 2.16 | 1.78 | 2.33 | 1.9 | 1.66 | |
PTB ratio | 2.16 | 1.78 | 2.33 | 1.9 | 1.66 | |
EV to sales | 29.99 | 126.18 | 147.46 | 71.74 | 382.34 | |
Enterprise value over EBITDA | -3.96 | -11.56 | -8.5 | -3.33 | -3.94 | |
EV to operating cash flow | -6.74 | -11.17 | -9.33 | -4.52 | -4.47 | |
EV to free cash flow | -6.35 | -9.9 | -8.96 | -4.37 | -4.42 | |
Earnings yield | -0.12 | 0.35 | 0 | -0.06 | -0.04 | |
Free cash flow yield | -0.13 | -0.09 | -0.09 | -0.15 | -0.2 | |
Debt to equity | 0.04 | 0.06 | 0.11 | 0.09 | 0.09 | |
Debt to assets | 0.03 | 0.04 | 0.08 | 0.05 | 0.07 | |
Net debt to EBITDA | 0.84 | 0.98 | 2.26 | 1.93 | 0.51 | |
Current ratio | 0.98 | 1.21 | 2.29 | 2.22 | 3.99 | |
Interest coverage | -265.35 | -51.21 | -40.57 | -31.88 | -50.04 | |
Income quality | 1.03 | -0.27 | -28.86 | 2.52 | 4.82 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
Payout ratio | -0.02 | 0 | 0 | -0.09 | -0.11 | |
Sales general and administrative to revenue | 1.49 | 4.02 | 3.18 | 3.08 | 17.07 | |
Research and developement to revenue | 3.5 | 7.5 | 7.34 | 8.17 | 55.56 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.06 | 0.13 | 0.04 | 0.04 | 0.01 | |
Capex to revenue | -0.27 | -1.44 | -0.65 | -0.57 | -1.04 | |
Capex to depreciation | -1.62 | -1.88 | -0.82 | -0.78 | -0.24 | |
Stock based compensation to revenue | 0.77 | 1.67 | 1.28 | 1.4 | 7.03 | |
Graham number | 2.43 | 8.88 | 0.92 | 3.19 | 2.4 | |
ROIC | -0.37 | -0.14 | -0.04 | -0.24 | -0.13 | |
Return on tangible assets | -0.16 | 0.45 | 0 | -0.07 | -0.05 | |
Graham Net | -0.09 | -0.45 | 0.26 | 0.43 | 0.73 | |
Working capital | -5.98M | 29.64M | 233.42M | 275.67M | 289.31M | |
Tangible asset value | 163.89M | 649.77M | 652.64M | 583.16M | 546.76M | |
Net current asset value | -15.01M | -121.94M | 77.89M | 139.95M | 231.13M | |
Invested capital | 0.04 | 0.06 | 0.11 | 0.09 | 0.09 | |
Average receivables | 0 | 1.16M | 2.63M | 3.26M | 7.95M | |
Average payables | 10.5M | 7.87M | 9.98M | 10.11M | 18.93M | |
Average inventory | 0 | 0.5 | 3.76M | 20.02M | 16.26M | |
Days sales outstanding | 0 | 97.76 | 128.61 | 131.27 | 2.15K | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 3.73 | 2.84 | 2.78 | 0.17 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.26 | 0.63 | 0.01 | -0.11 | -0.07 | |
Capex per share | -0.02 | -0.04 | -0.02 | -0.02 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.02 | 0.02 | 0.01 | 0.01 | |
Net income per share | 0 | -0.04 | -0.04 | -0.04 | -0.04 | |
Operating cash flow per share | 0 | -0.17 | -0.17 | -0.12 | -0.12 | |
Free cash flow per share | 0 | -0.17 | -0.17 | -0.12 | -0.12 | |
Cash per share | 0 | 1.27 | 1.27 | 1.26 | 1.27 | |
Book value per share | 0 | 1.97 | 1.97 | 1.85 | 1.85 | |
Tangible book value per share | 0 | 1.98 | 1.98 | 1.83 | 1.83 | |
Share holders equity per share | 0 | 1.97 | 1.97 | 1.85 | 1.85 | |
Interest debt per share | 0 | 0.04 | 0.17 | 0.37 | 0.09 | |
Market cap | 0 | 761.06M | 889.56M | 762.3M | 761.39M | |
Enterprise value | -317.81M | 611.2M | 786.57M | 411.79M | 436.45M | |
P/E ratio | 0 | -17.29 | -20.21 | -15.24 | -15.23 | |
Price to sales ratio | 0 | 177.26 | 207.19 | 484 | 483.42 | |
POCF ratio | 0 | -16.63 | -19.43 | -23.41 | -23.38 | |
PFCF ratio | 0 | -16.53 | -19.32 | -23.38 | -23.35 | |
P/B Ratio | 0 | 1.4 | 1.64 | 1.48 | 1.48 | |
PTB ratio | 0 | 1.4 | 1.64 | 1.48 | 1.48 | |
EV to sales | 0 | 142.35 | 183.2 | 261.45 | 277.11 | |
Enterprise value over EBITDA | 0 | -13.07 | -16.82 | -11.27 | -11.94 | |
EV to operating cash flow | 0 | -13.35 | -17.18 | -12.64 | -13.4 | |
EV to free cash flow | 0 | -13.28 | -17.09 | -12.63 | -13.39 | |
Earnings yield | 0 | -0.01 | -0.01 | -0.02 | -0.02 | |
Free cash flow yield | 0 | -0.06 | -0.05 | -0.04 | -0.04 | |
Debt to equity | 0.08 | 0.02 | 0.09 | 0.2 | 0.05 | |
Debt to assets | 0.06 | 0.01 | 0.07 | 0.15 | 0.04 | |
Net debt to EBITDA | 0 | 3.2 | 2.2 | 9.59 | 8.89 | |
Current ratio | 2.54 | 3.99 | 3.99 | 7.31 | 7.31 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 4.16 | 4.16 | 2.6 | 2.6 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 4.35 | 4.35 | 8.31 | 8.31 | |
Research and developement to revenue | 0 | 7.9 | 7.9 | 16.87 | 16.87 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0.01 | 0.01 | 0 | 0 | |
Capex to revenue | 0 | -0.06 | -0.06 | -0.02 | -0.02 | |
Capex to depreciation | 0 | -0.12 | -0.12 | -0.02 | -0.02 | |
Stock based compensation to revenue | 0 | 1.3 | 1.3 | 0.4 | 0.4 | |
Graham number | 0 | 1.33 | 1.33 | 1.37 | 1.37 | |
ROIC | 0 | -0.14 | -0.13 | -0.11 | -0.13 | |
Return on tangible assets | 0 | -0.02 | -0.02 | -0.02 | -0.02 | |
Graham Net | 0 | 0.74 | 0.74 | 0.6 | 0.61 | |
Working capital | 231.56M | 289.31M | 289.31M | 310.83M | 310.83M | |
Tangible asset value | 575.06M | 546.76M | 546.76M | 507.96M | 507.96M | |
Net current asset value | 134.68M | 231.13M | 231.13M | 175.44M | 175.44M | |
Invested capital | 0.08 | 0.02 | 0.09 | 0.2 | 0.05 | |
Average receivables | 0 | 7.96M | 12.32M | 7.31M | 2.3M | |
Average payables | 0 | 20.8M | 26.5M | 17.61M | 8.73M | |
Average inventory | 0 | 5.09M | 1 | 0.5 | -812K | |
Days sales outstanding | 0 | 258.19 | 258.19 | 131.49 | 131.49 | |
Days payables outstanding | 0 | 56.4 | 56.41 | 29.55 | 29.55 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | -5.5 | |
Receivables turnover | 0 | 0.35 | 0.35 | 0.68 | 0.68 | |
Payables turnover | 0 | 1.6 | 1.6 | 3.05 | 3.05 | |
Inventory turnover | 0 | 42.29M | 42.29M | 0 | -16.36 | |
ROE | 0 | -0.02 | -0.02 | -0.02 | -0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
PRTC.L Frequently Asked Questions
What is PureTech Health plc stock symbol ?
PureTech Health plc is a US stock , located in Boston of Ma and trading under the symbol PRTC.L
What is PureTech Health plc stock quote today ?
PureTech Health plc stock price is $225 today.
Is PureTech Health plc stock public?
Yes, PureTech Health plc is a publicly traded company.